(NEM) Newmont Goldcorp - Ratings and Ratios
Gold,Copper,Silver,Zinc,Lead
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.10% |
| Yield on Cost 5y | 2.00% |
| Yield CAGR 5y | -0.98% |
| Payout Consistency | 86.2% |
| Payout Ratio | 17.3% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 42.0% |
| Value at Risk 5%th | 64.6% |
| Relative Tail Risk | -6.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.05 |
| Alpha | 103.17 |
| CAGR/Max DD | 0.62 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.377 |
| Beta | 0.540 |
| Beta Downside | 0.449 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.60% |
| Mean DD | 16.96% |
| Median DD | 18.69% |
Description: NEM Newmont Goldcorp September 25, 2025
Newmont Corporation (NYSE: NEM) is a diversified mining company primarily focused on gold production and exploration, while also pursuing copper, silver, zinc, lead, and other base metals across a global portfolio that includes assets in North America, South America, Africa, Oceania, and the Caribbean. Founded in 1916 and headquartered in Denver, Colorado, the firm operates both mature mines and development projects, positioning itself as one of the world’s largest gold producers.
Key recent metrics: in 2023 Newmont delivered approximately 5.9 million ounces of gold, generating an all-in sustaining cost (AISC) of about $1,020 per ounce, and reported free cash flow of $2.3 billion, reflecting a 12 % increase year-over-year. The company’s exposure to copper is growing through the Ahafo and Ahafo-Birim projects in Ghana, where copper-by-product credits are expected to improve overall margins. Macro-driven catalysts include a persistently high gold price (averaging $1,950/oz in 2023) supported by elevated inflation expectations and a low-interest-rate environment, while sector-wide supply constraints from declining ore grades and tighter ESG regulations add a structural premium to gold miners.
Given the blend of solid cash generation, expanding copper exposure, and favorable macro trends, a deeper dive into Newmont’s valuation assumptions-particularly the sensitivity of its AISC to commodity price swings-could be worthwhile; you might find ValueRay’s detailed model inputs helpful for that analysis.
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income (7.19b TTM) > 0 and > 6% of Revenue (6% = 1.27b TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 9.38pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 24.88% (prev 36.65%; Δ -11.78pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.17 (>3.0%) and CFO 9.22b > Net Income 7.19b (YES >=105%, WARN >=100%) |
| Net Debt (11.0m) to EBITDA (13.37b) ratio: 0.00 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.04 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (1.10b) change vs 12m ago -4.26% (target <= -2.0% for YES) |
| Gross Margin 45.63% (prev 21.57%; Δ 24.06pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 38.33% (prev 29.96%; Δ 8.37pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 36.42 (EBITDA TTM 13.37b / Interest Expense TTM 289.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.30
| (A) 0.10 = (Total Current Assets 10.37b - Total Current Liabilities 5.09b) / Total Assets 54.69b |
| (B) 0.05 = Retained Earnings (Balance) 2.70b / Total Assets 54.69b |
| (C) 0.19 = EBIT TTM 10.53b / Avg Total Assets 55.43b |
| (D) 0.21 = Book Value of Equity 4.57b / Total Liabilities 21.28b |
| Total Rating: 2.30 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 93.37
| 1. Piotroski 9.0pt |
| 2. FCF Yield 6.46% |
| 3. FCF Margin 28.81% |
| 4. Debt/Equity 0.17 |
| 5. Debt/Ebitda 0.00 |
| 6. ROIC - WACC (= 11.46)% |
| 7. RoE 22.72% |
| 8. Rev. Trend 81.38% |
| 9. EPS Trend 69.08% |
What is the price of NEM shares?
Over the past week, the price has changed by +10.71%, over one month by +15.46%, over three months by +25.83% and over the past year by +118.99%.
Is NEM a buy, sell or hold?
- Strong Buy: 10
- Buy: 3
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the NEM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 103.6 | 14.4% |
| Analysts Target Price | 103.6 | 14.4% |
| ValueRay Target Price | 97.9 | 8.2% |
NEM Fundamental Data Overview November 25, 2025
P/E Trailing = 13.4572
P/E Forward = 11.6414
P/S = 4.4203
P/B = 2.7421
P/EG = 1.7914
Beta = 0.441
Revenue TTM = 21.25b USD
EBIT TTM = 10.53b USD
EBITDA TTM = 13.37b USD
Long Term Debt = 5.18b USD (from longTermDebt, last quarter)
Short Term Debt = 116.0m USD (from shortTermDebt, last quarter)
Debt = 5.65b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 11.0m USD (from netDebt column, last quarter)
Enterprise Value = 94.73b USD (95.05b + Debt 5.65b - CCE 5.97b)
Interest Coverage Ratio = 36.42 (Ebit TTM 10.53b / Interest Expense TTM 289.0m)
FCF Yield = 6.46% (FCF TTM 6.12b / Enterprise Value 94.73b)
FCF Margin = 28.81% (FCF TTM 6.12b / Revenue TTM 21.25b)
Net Margin = 33.82% (Net Income TTM 7.19b / Revenue TTM 21.25b)
Gross Margin = 45.63% ((Revenue TTM 21.25b - Cost of Revenue TTM 11.55b) / Revenue TTM)
Gross Margin QoQ = 48.29% (prev 47.58%)
Tobins Q-Ratio = 1.73 (Enterprise Value 94.73b / Total Assets 54.69b)
Interest Expense / Debt = 0.92% (Interest Expense 52.0m / Debt 5.65b)
Taxrate = 29.92% (787.0m / 2.63b)
NOPAT = 7.38b (EBIT 10.53b * (1 - 29.92%))
Current Ratio = 2.04 (Total Current Assets 10.37b / Total Current Liabilities 5.09b)
Debt / Equity = 0.17 (Debt 5.65b / totalStockholderEquity, last quarter 33.23b)
Debt / EBITDA = 0.00 (Net Debt 11.0m / EBITDA 13.37b)
Debt / FCF = 0.00 (Net Debt 11.0m / FCF TTM 6.12b)
Total Stockholder Equity = 31.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.14% (Net Income 7.19b / Total Assets 54.69b)
RoE = 22.72% (Net Income TTM 7.19b / Total Stockholder Equity 31.63b)
RoCE = 28.60% (EBIT 10.53b / Capital Employed (Equity 31.63b + L.T.Debt 5.18b))
RoIC = 19.06% (NOPAT 7.38b / Invested Capital 38.70b)
WACC = 7.60% (E(95.05b)/V(100.70b) * Re(8.01%) + D(5.65b)/V(100.70b) * Rd(0.92%) * (1-Tc(0.30)))
Discount Rate = 8.01% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 33.33 | Cagr: 6.00%
[DCF Debug] Terminal Value 77.15% ; FCFE base≈4.08b ; Y1≈3.79b ; Y5≈3.46b
Fair Price DCF = 56.94 (DCF Value 62.14b / Shares Outstanding 1.09b; 5y FCF grow -9.10% → 3.0% )
EPS Correlation: 69.08 | EPS CAGR: 23.28% | SUE: 1.85 | # QB: 4
Revenue Correlation: 81.38 | Revenue CAGR: 13.11% | SUE: 0.08 | # QB: 0
Additional Sources for NEM Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle